Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experiment (DCE) to Support Novo Nordisk's Long-Acting Insulin

Inclusion Criteria

• •Patient is an adult aged 18 years or over
• •Patient was diagnosed with type-2 diabetes mellitus (T2DM) greater than or equal to 180 days prior to the day of screening
• •Patient is currently prescribed a diabetes treatment (e.g., Metformin/Sus, DPP4i, SGLT2i, GLP-1 RA and/or basal insulin)
• •Patient is willing and able to provide written informed consent to participate
• •For qualitative interviews:
• •Patient is a fluent speaker of English and is able to read, write, and fully understand the English language
• •Patient is a resident in Canada
• •For quantitative online survey:
• •Patient is a fluent speaker of the local language (English/French/Spanish or Japanese) and is able to read, write and fully understand the local language
• •Patient is a resident of either Canada, France, Spain or Japan